Diabetes Care 32:16001602 Greenfield JR, Farooqi IS, Keogh JM et al (2009) Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects
The article says allulose is a rare sugar that may stimulate the body's own GLP-1 secretion rather than binding GLP-1 receptors directly
The first few days focus on satiety and simplicity In the initial phase, it's not about counting calories or starving yourself
A review of liver biopsies performed in patients with NAFLD reported NASH prevalence rates ranging from 6.7% to 59% depending on whether the procedure was done in the absence or presence of a specific "clinical indication".3 Focussing on the only prospective prevalence study of NASH to date, the prevalence of NASH among patients presenting for routine colon cancer screening was 12%.14 The public health impact of NAFLD is significant given the worldwide disease burden and the associated morbidity and mortality
The dysregulation at this level enhances the activation of glial cells
Safety, Eligibility, and Provider-Guided Decision-Making GLP-1 medications are not appropriate for everyone
